Home / Business and Economy / Rho Nutrition Explores $500M+ Sale Amid Health Boom
Rho Nutrition Explores $500M+ Sale Amid Health Boom
28 Oct
Summary
- Rho Nutrition is exploring a sale valuing the company over $500 million.
- The company anticipates generating approximately $200 million in revenue this year.
- Founded in 2022, Rho specializes in liquid supplements using liposome technology.
Rho Nutrition, a significant player in the liquid supplements and vitamins market, is currently exploring a potential sale. This strategic move could see the company valued at more than $500 million. The privately held firm is engaged in preliminary discussions, working with investment bank Rothschild to navigate the sale process. Preliminary revenue projections indicate that Rho anticipates generating approximately $200 million in revenue by the end of this year.
Established in 2022 by industry veterans Ryan Bishop and George Padilla, Rho Nutrition focuses on a range of health areas. Their innovative product line targets cellular, skin, hair, brain, heart, and hormonal health. A key differentiator for Rho is its use of liposomes—tiny, fat-like bubbles designed to protect nutrients during digestion, thereby improving their absorption compared to conventional vitamin delivery methods.